Gesine Meyer-Rath | Profiles RNS

Gesine Meyer-Rath, MD, PhD

Research Associate Professor

Boston University School of Public Health

Dept of Global Health

MD, Freie Universität Berlin
PhD, Freie Universität Berlin

Websites

School of Public Health Faculty

ORCID : 0000-0003-0439-381X

Dr Meyer-Rath is a Research Associate Professor at the Center for Global Health and Development of the Boston University School of Public Health. She is a physician and health economist working on the economics of HIV and antiretroviral treatment in low- and middle-income countries. Her focus lies on modeling methods for economic evaluation, including infectious disease modeling and decision analysis, and translating research into recommendations for public policy. Before joining CGHD she has worked in the Pediatrics Department of Charité University Hospital Berlin, at the World Health Organization and at the London School of Hygiene and Tropical Medicine.

Dr Meyer-Rath is currently based in Johannesburg where she works at the Health Economics and Epidemiology Research Office (HE2RO), a collaboration between Boston University and the University of the Witwatersrand. She holds a PhD in Health Economics from the London School of Hygiene and Tropical Medicine as well as a MD/PhD in Physiology from Free University Berlin.

2010 International AIDS Society/ ANRS: Young Investigator Award

BU Sponsored Research

Enhancing the evidence-base for HIV self-testing in young men
04/17/2018 - 03/31/2020 (PI)
WITS Health Consortium (PTY) LTD Bill & Melinda Gates

Identifying optimal HIV testing strategies to achieve high levels of HIV diagnosis in South Africa
09/01/2016 - 07/31/2017 (PI)
Imperial College Bill & Melinda Gates

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

Meyer-Rath G, van Rensburg C, Chiu C, Leuner R, Jamieson L, Cohen S. The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case. PLoS One. 2019; 14(2):e0210497. PMID: 30807573.
Campos NG, Lince-Deroche N, Chibwesha CJ, Firnhaber C, Smith JS, Michelow P, Meyer-Rath G, Jamieson L, Jordaan S, Sharma M, Regan C, Sy S, Liu G, Tsu V, Jeronimo J, Kim JJ. Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study. J Acquir Immune Defic Syndr. 2018 Oct 01; 79(2):195-205. PMID: 29916959.
Meyer-Rath G, McGillen JB, Cuadros DF, Hallett TB, Bhatt S, Wabiri N, Tanser F, Rehle T. Targeting the right interventions to the right people and places: the role of geospatial analysis in HIV program planning. AIDS. 2018 05 15; 32(8):957-963. PMID: 29547437.
Quaife M, Terris-Prestholt F, Eakle R, Cabrera Escobar MA, Kilbourne-Brook M, Mvundura M, Meyer-Rath G, Delany-Moretlwe S, Vickerman P. The cost-effectiveness of multi-purpose HIV and pregnancy prevention technologies in South Africa. J Int AIDS Soc. 2018 03; 21(3). PMID: 29537654.
Meyer-Rath G, Johnson LF, Pillay Y, Blecher M, Brennan AT, Long L, Moultrie H, Sanne I, Fox MP, Rosen S. Changing the South African national antiretroviral therapy guidelines: The role of cost modelling. PLoS One. 2017; 12(10):e0186557.View Related Profiles.
Brennan, Alana
Meyer-Rath, Gesine
Sanne, Ian
Long, Lawrence
Fox, Matthew
Rosen, Sydney
PMID: 29084275.
Meyer-Rath G, van Rensburg C, Larson B, Jamieson L, Rosen S. Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case. PLoS One. 2017; 12(10):e0186496.View Related Profiles.
Larson, Bruce
Meyer-Rath, Gesine
Rosen, Sydney
PMID: 29073167.
Nichols BE, Meyer-Rath G. Cost-effectiveness of early identification of HIV infection. Lancet HIV. 2017 10; 4(10):e431-e432. PMID: 28768605.
Bor J, Ahmed S, Fox MP, Rosen S, Meyer-Rath G, Katz IT, Tanser F, Pillay D, Bärnighausen T. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: An empirical modeling study. PLoS One. 2017; 12(6):e0178249.View Related Profiles.
Meyer-Rath, Gesine
Bor, Jacob
Fox, Matthew
Rosen, Sydney
PMID: 28617805.
Mikkelsen E, Hontelez JA, Jansen MP, Bärnighausen T, Hauck K, Johansson KA, Meyer-Rath G, Over M, de Vlas SJ, van der Wilt GJ, Tromp N, Bijlmakers L, Baltussen RM. Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints. PLoS Med. 2017 Feb; 14(2):e1002240. PMID: 28222126; DOI: 10.1371/journal.pmed.1002240;.
Chiu C, Johnson LF, Jamieson L, Larson BA, Meyer-Rath G. Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered? BMC Public Health. 2017 Jan 31; 17(1):143.View Related Profiles.
Larson, Bruce
Meyer-Rath, Gesine
PMID: 28143525; DOI: 10.1186/s12889-017-4023-3;.

Showing 10 of 40 results. Show More

Shearer K, Clouse K, Meyer-Rath G, MacLeod W, Maskew M, Sanne I, Long L, Fox MP. Citizenship status and engagement in HIV care: an observational cohort study to assess the association between reporting a national ID number and retention in public-sector HIV care in Johannesburg, South Africa. BMJ Open. 2017 Jan 24; 7(1):e013908.View Related Profiles.
Meyer-Rath, Gesine
Sanne, Ian
Long, Lawrence
Fox, Matthew
MacLeod, William
PMID: 28119389; DOI: 10.1136/bmjopen-2016-013908;.
Johnson LF, Chiu C, Myer L, Davies MA, Dorrington RE, Bekker LG, Boulle A, Meyer-Rath G. Prospects for HIV control in South Africa: a model-based analysis. Glob Health Action. 2016; 9:30314. PMID: 27282146; PMCID: PMC4901512; DOI: 10.3402/gha.v9.30314;.
Stover J, Bollinger L, Izazola JA, Loures L, DeLay P, Ghys PD. What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach. PLoS One. 2016; 11(5):e0154893. PMID: 27159260; DOI: 10.1371/journal.pone.0154893;.
Blecher M, Meyer-Rath G, Chiu C, Pillay Y, Abdullah F, Kollipara A, Daven J, Borowitz M, Tavanxi N. South African Health Review 2015/16. HIV/AIDS financing in South Africa: Sustainability and fiscal space. Health Systems Trust. Durban. 2016.
Johnson LF, Chiu C, Myer L, Davies MA, Dorrington RE, Bekker LG, Boulle A, Meyer-Rath G. Prospects for HIV control in South Africa: a model-based analysis. Glob Health Action. 2016 Jan; 9(1):30314. PMID: 28157035; DOI: 10.3402/gha.v9.30314;.
Meyer-Rath G, Pienaar J, Brink B, van Zyl A, Muirhead D, Grant A, Churchyard G, Watts C, Vickerman P. The Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit Analysis. PLoS Med. 2015 Sep; 12(9):e1001869. PMID: 26327271; PMCID: PMC4556678; DOI: 10.1371/journal.pmed.1001869;.
Siegel G, Meyer-Rath G, Ermilova E, Rodríguez M, Malmsten M, Claesson P, Saunders R, Hetzer H, Lindman B. Flow Sensing in the Cardiovascular System. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2015; 480:318-327.
Fox MP, Shearer K, Maskew M, Meyer-Rath G, Clouse K, Sanne I. Attrition through multiple stages of pre-treatment and ART HIV care in South Africa. PLoS One. 2014; 9(10):e110252.View Related Profiles.
Meyer-Rath, Gesine
Sanne, Ian
Fox, Matthew
PMID: 25330087; PMCID: PMC4203772; DOI: 10.1371/journal.pone.0110252;.
Iyer HS, Scott CA, Lembela Bwalya D, Meyer-Rath G, Moyo C, Bolton Moore C, Larson BA, Rosen S. Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia. AIDS Res Treat. 2014; 2014:235483.View Related Profiles.
Larson, Bruce
Scott, Callie
Meyer-Rath, Gesine
Rosen, Sydney
PMID: 24711925.
Terris-Prestholt F, Foss AM, Cox AP, Heise L, Meyer-Rath G, Delany-Moretlwe S, Mertenskoetter T, Rees H, Vickerman P, Watts CH. Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices. BMC Infect Dis. 2014; 14:14. PMID: 24405719; PMCID: PMC3899035; DOI: 10.1186/1471-2334-14-14;.
Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2014 Jan; 2(1):e23-34. PMID: 25104632; DOI: 10.1016/S2214-109X(13)70172-4;.
Eaton JW, Menzies NA, Stover J, Cambiano V, Chindelevitch L, Cori A, Hontelez JA, Humair S, Kerr CC, Klein DJ, Mishra S, Mitchell KM, Nichols BE, Vickerman P, Bakker R, Bärnighausen T, Bershteyn A, Bloom DE, Boily MC, Chang ST, Cohen T, Dodd PJ, Fraser C, Gopalappa C, Lundgren J, Martin NK, Mikkelsen E, Mountain E, Pham QD, Pickles M, Phillips A, Platt L, Pretorius C, Prudden HJ, Salomon JA, van de Vijver DA, de Vlas SJ, Wagner BG, White RG, Wilson DP, Zhang L, Blandford J, Meyer-Rath G, Remme M, Revill P, Sangrujee N, Terris-Prestholt F, Doherty M, Shaffer N, Easterbrook PJ, Hirnschall G, Hallett TB. Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health. 2013 Dec 10; 2(1):23-34. PMID: 25083415.
Schnippel K, Long L, Meyer-Rath G, Sanne I, Rosen S, Stevens W. Impact and costs of algorithms for the diagnosis of adults with pulmonary tuberculosis in South Africa. S Afr Med J. 2013 Jul; 103(7):436.View Related Profiles.
Meyer-Rath, Gesine
Sanne, Ian
Rosen, Sydney
PMID: 23946950.
Scott CA, Iyer H, Bwalya DL, McCoy K, Meyer-Rath G, Moyo C, Bolton-Moore C, Larson B, Rosen S. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis. PLoS One. 2013; 8(6):e67910.View Related Profiles.
Larson, Bruce
Scott, Callie
Meyer-Rath, Gesine
Rosen, Sydney
PMID: 23840788; PMCID: PMC3695874; DOI: 10.1371/journal.pone.0067910;.
Meyer-Rath G, Brennan AT, Fox MP, Modisenyane T, Tshabangu N, Mohapi L, Rosen S, Martinson N. Rates and cost of hospitalization before and after initiation of antiretroviral therapy in urban and rural settings in South Africa. J Acquir Immune Defic Syndr. 2013 Mar 1; 62(3):322-328.View Related Profiles.
Brennan, Alana
Meyer-Rath, Gesine
Fox, Matthew
Rosen, Sydney
PMID: 23187948; PMCID: PMC3625673.
Meyer-Rath G, Brennan A, Long L, Ndibongo B, Technau K, Moultrie H, Fairlie L, Coovadia A, Rosen S. Cost and outcomes of paediatric antiretroviral treatment in South Africa. AIDS. 2013 Jan 14; 27(2):243-50.View Related Profiles.
Brennan, Alana
Meyer-Rath, Gesine
Long, Lawrence
Rosen, Sydney
PMID: 23014517; DOI: 10.1097/QAD.0b013e32835a5b92;.
Schnippel K, Meyer-Rath G, Long L, Stevens WS, Sanne I, Rosen S. Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa. S Afr Med J. 2013 Feb; 103(2):101-6.View Related Profiles.
Meyer-Rath, Gesine
Sanne, Ian
Long, Lawrence
Rosen, Sydney
PMID: 23374320; DOI: 10.7196/samj.6182;.
Meyer-Rath G, Miners A, Santos AC, Variava E, Venter WD. Cost and resource use of patients on antiretroviral therapy in the urban and semiurban public sectors of South Africa. J Acquir Immune Defic Syndr. 2012 Nov 1; 61(3):e25-32. PMID: 22895437; DOI: 10.1097/QAI.0b013e31826cc575;.
Kranzer K, Lawn SD, Meyer-Rath G, Vassall A, Raditlhalo E, Govindasamy D, van Schaik N, Wood R, Bekker LG. Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study. PLoS Med. 2012; 9(8):e1001281. PMID: 22879816; PMCID: PMC3413719; DOI: 10.1371/journal.pmed.1001281;.
Meyer-Rath G, Over M. HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions. PLoS Med. 2012; 9(7):e1001247. PMID: 22802731; PMCID: PMC3393674; DOI: 10.1371/journal.pmed.1001247;.
HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making. PLoS Med. 2012; 9(7):e1001259. PMID: 22802739; PMCID: PMC3393655; DOI: 10.1371/journal.pmed.1001259;.
Schnippel K, Meyer-Rath G, Long L, MacLeod W, Sanne I, Stevens WS, Rosen S. Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa. Trop Med Int Health. 2012 Sep; 17(9):1142-51.View Related Profiles.
Meyer-Rath, Gesine
Sanne, Ian
Rosen, Sydney
MacLeod, William
PMID: 22686606; PMCID: PMC3506730; DOI: 10.1111/j.1365-3156.2012.03028.x;.
Meyer-Rath G, Schnippel K, Long L, MacLeod W, Sanne I, Stevens W, Pillay S, Pillay Y, Rosen S. The impact and cost of scaling up GeneXpert MTB/RIF in South Africa. PLoS One. 2012; 7(5):e36966.View Related Profiles.
Meyer-Rath, Gesine
Sanne, Ian
Rosen, Sydney
MacLeod, William
PMID: 22693561; PMCID: PMC3365041; DOI: 10.1371/journal.pone.0036966;.
Vickerman P, Devine A, Foss AM, Delany-Moretlwe S, Mayaud P, Meyer-Rath G. The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa. Sex Transm Dis. 2011 May; 38(5):401-9. PMID: 21317689; DOI: 10.1097/OLQ.0b013e31820b8bc8;.
McCarthy K, Chersich MF, Vearey J, Meyer-Rath G, Jaffer A, Simpwalo S, Venter WD. Good treatment outcomes among foreigners receiving antiretroviral therapy in Johannesburg, South Africa. Int J STD AIDS. 2009 Dec; 20(12):858-62. PMID: 19948901; DOI: 10.1258/ijsa.2009.009258;.
Renaud A, Basenya O, de Borman N, Greindl I, Meyer-Rath G. The cost effectiveness of integrated care for people living with HIV including antiretroviral treatment in a primary health care centre in Bujumbura, Burundi. AIDS Care. 2009 Nov; 21(11):1388-94. PMID: 20024715; DOI: 10.1080/09540120902884042;.
Meyer-Rath G. The cost effectiveness of HIV control: Getting the priorities right. Southern African Journal of HIV Medicine. 2007; 28:15-16.
Meyer-Rath G, Marlise Richter. User fees, transport cost, and the ethics of exemption: How free is free ART?. Southern African Journal of HIV Medicine. 2007; 28:52-56.
Boehme C, Meyer-Rath G, Keitzer R, Luck W. Abdominal tuberculosis in children. Monatsschr Kinderheilkunde. 2007; 155:S16-S19.
Siegel S, Malmsten M, Fischer M, Meyer-Rath G, Hiemann N, Hetzer R. The role of the proteoglycan receptor in lipoprotein binding. Int J Angiol. 2003; 12:1-7.

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 40 publications over 12 distinct years, with a maximum of 7 publications in 2013 and 2017

Bar chart showing 40 publications over 12 distinct years, with a maximum of 7 publications in 2013 and 2017

Year	Publications
2003	1
2007	3
2009	2
2011	1
2012	6
2013	7
2014	3
2015	2
2016	4
2017	7
2018	3
2019	1

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

HIV, economic evaluation, costs, investment case, antiretroviral treatment

Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

617.414.1260

Download vCard

Meyer-Rath's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (117) concept(s)

Co-Authors

See all (9) people

Similar People

See all (60) people

Same Department

Search Department